Drug recall
buPROPion Hydrochloride Extended-Release Tablets, USP (XL) 150mg, 30-count bottles, Rx Only, Manufactured for…
FDA recall event 93706 · Class II · Rising Pharma Holding, Inc.
Key facts
| Event ID | 93706 |
|---|---|
| Recall numbers | D-0222-2024 |
| Recalling firm | Rising Pharma Holding, Inc. |
| Product type | Drugs |
| Products | buPROPion Hydrochloride Extended-Release Tablets, USP (XL) 150mg, 30-count bottles, Rx Only, Manufactured for: Rising Pharma Holdings, Inc. East Brunswick, NJ 08816 Manufactured by: Graviti… |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Presence of Foreign Tablets/Capsules |
| Initiation date | Dec 29, 2023 |
| Report date | Jan 17, 2024 |
| City | East Brunswick |
| State | NJ |
| Country | United States |
| FEI number | 3015784623 |
At a glance
- 1–9 Products in this recall
- 1–9 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: